A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019

Jin Yong Kim, Oana Săndulescu, Liliana-Lucia Preotescu, Norma E Rivera-Martínez, Marta Dobryanska, Victoria Birlutiu, Egidia G Miftode, Natalia Gaibu, Olga Caliman-Sturdza, Simin-Aysel Florescu, Hye Jin Shi, Anca Streinu-Cercel, Adrian Streinu-Cercel, Sang Joon Lee, Sung Hyun Kim, Ilsung Chang, Yun Ju Bae, Jee Hye Suh, Da Rae Chung, Sun Jung Kim, Mi Rim Kim, Seul Gi Lee, Gahee Park, Joong Sik Eom

Open source

DOI: 10.1093/ofid/ofac406
Published: 2022-08-01
Container: Open Forum Infectious Diseases
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ofid/ofac406,
  title = {A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019},
  author = {Jin Yong Kim and Oana Săndulescu and Liliana-Lucia Preotescu and Norma E Rivera-Martínez and Marta Dobryanska and Victoria Birlutiu and Egidia G Miftode and Natalia Gaibu and Olga Caliman-Sturdza and Simin-Aysel Florescu and Hye Jin Shi and Anca Streinu-Cercel and Adrian Streinu-Cercel and Sang Joon Lee and Sung Hyun Kim and Ilsung Chang and Yun Ju Bae and Jee Hye Suh and Da Rae Chung and Sun Jung Kim and Mi Rim Kim and Seul Gi Lee and Gahee Park and Joong Sik Eom},
  year = {2022},
  journal = {Open Forum Infectious Diseases},
  doi = {10.1093/ofid/ofac406},
  url = {https://doi.org/10.1093/ofid/ofac406}
}

RIS

TY  - JOUR
TI  - A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019
AU  - Jin Yong Kim
AU  - Oana Săndulescu
AU  - Liliana-Lucia Preotescu
AU  - Norma E Rivera-Martínez
AU  - Marta Dobryanska
AU  - Victoria Birlutiu
AU  - Egidia G Miftode
AU  - Natalia Gaibu
AU  - Olga Caliman-Sturdza
AU  - Simin-Aysel Florescu
AU  - Hye Jin Shi
AU  - Anca Streinu-Cercel
AU  - Adrian Streinu-Cercel
AU  - Sang Joon Lee
AU  - Sung Hyun Kim
AU  - Ilsung Chang
AU  - Yun Ju Bae
AU  - Jee Hye Suh
AU  - Da Rae Chung
AU  - Sun Jung Kim
AU  - Mi Rim Kim
AU  - Seul Gi Lee
AU  - Gahee Park
AU  - Joong Sik Eom
PY  - 2022
JO  - Open Forum Infectious Diseases
DO  - 10.1093/ofid/ofac406
UR  - https://doi.org/10.1093/ofid/ofac406
ER  -

APA

Kim, J. Y., Săndulescu, O., Preotescu, L., Rivera-Martínez, N. E., Dobryanska, M., Birlutiu, V., Miftode, E. G., Gaibu, N., Caliman-Sturdza, O., Florescu, S., Shi, H. J., Streinu-Cercel, A., Streinu-Cercel, A., Lee, S. J., Kim, S. H., Chang, I., Bae, Y. J., Suh, J. H., Chung, D. R., Kim, S. J., Kim, M. R., Lee, S. G., Park, G., & Eom, J. S. (2022). A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019. Open Forum Infectious Diseases. https://doi.org/10.1093/ofid/ofac406

Source records

crossref · retrieved 2026-09-27T02:25:17.342Z